相关实验视频

Updated: May 14, 2025

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors

Published on: September 14, 2019

扩大基因疗法的潜力对杜恩肌肉发育不良症

Gyas Khan¹, Md Sadique Hussain²

¹Department of Pharmacology and Toxicology, College of Pharmacy, Jazan University, Jazan, Saudi Arabia.

Current pharmaceutical design

|May 13, 2025

概括

基因疗法为杜恩肌肉发育不良症 (DMD) 提供了一个有希望的途径,旨在解决遗传缺陷,而不仅仅是症状. 腺相关病毒 (AAV) 载体的进步显示了恢复氨酸表达的潜力,尽管仍然存在挑战.

科学领域:

神经肌肉疾病神经肌肉疾病
遗传医学是一种遗传医学.
生物技术是生物技术.

背景情况:

杜恩肌肉发育不良 (DMD) 是一种严重的X系遗传疾病,导致逐渐的肌肉退化和早期死亡.
目前对DMD的治疗方法提供症状缓解,但不能纠正潜在的遗传缺陷.
基因疗法,特别是使用腺相关病毒 (AAV) 载体,提出了一种针对DMD遗传原因的新策略.

研究的目的:

审查当前的进展和临床里程碑在杜申尼肌肉发育不良的基因疗法.
讨论由腺相关病毒 (AAV) 介导的微型基因基因疗法的潜力.
确定DMD基因疗法的临床转化面临的挑战和未来方向.

主要方法:

对杜申尼肌肉发育不良症的基因疗法的当前文献的综述.
对AAV介导基因疗法的早期临床试验数据的分析.
探索新兴技术,如优化的AAV体和CRISPR-Cas9.9等.

主要成果:

通过AAV介导的微基因基因疗法的早期临床试验显示出有希望的安全性和转基因表达.
挑战包括免疫反应,可变的功能结果和长期耐用性.
为了克服这些障碍,正在探索矢量设计,免疫调节和基因组编辑方面的创新.

结论:

基因疗法通过解决疾病的遗传基础,具有治疗杜申肌肉衰竭的巨大潜力.
需要进一步的研究来优化剂量,确保长期的疗效,并促进公平获得这些先进疗法.
可扩展的制造和现实世界的数据集成对于DMD基因疗法的成功临床转化至关重要.

关键词:

AAV 矢量 AAV 矢量克里斯普尔-Cas9是什么意思临床试验是指临床试验中的临床试验.消极蛋白质是一种消极蛋白质.基因编辑基因编辑微型消毒素微型消毒素微型消毒素肌肉发育不良. 肌肉发育不良. 肌肉发育不良.

更多相关视频

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Published on: August 2, 2018

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice

Published on: April 10, 2019

相关概念视频

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...

Satellite Stem Cells and Muscular Dystrophy

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...

What is Genetic Engineering?

What is Genetic Engineering?